Market Chatter: Novo Nordisk Halves Wegovy Prices in Parts of China

06:43 AM EST, 12/29/2025 (MT Newswires) -- Novo Nordisk (NOVO-B.CO) reduced the price of its weight loss drug Wegovy in some parts of China by half, Bloomberg reported Monday, citing local news outlet Yicai. The price was slashed ahead of the March 2026 expiry of the Danish drugmaker's Chinese patent on semaglutide, which is the active ingredient for Wegovy, the news report states. Novo Nordisk did not immediately respond to a request for comment from MT Newswires. (Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)